We are delighted to share our work on structural variants at BRCA1/2 as a common source of homologous repair deficiency (HRD) in high grade serous ovarian carcinoma (HGSOC) bioRxiv. Here’s a #tweetorial to explain our findings… biorxiv.org/content/10.110… Thread, 1/11

.Edinburgh Cancer Research’s Robert Hollis (HobbRollis), Simon Herington and Charlie Gourley are co-authors on an abstract on an integrated analysis study in ovarian cancer at #AACR20 Virtual Meeting II. Register for free to access: abstractsonline.com/pp8/#!/9045/pr…

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome - important research led by our investigators published in Nature Communications ! nature.com/articles/s4146…

Molecular dissection of synchronous ovarian and endometrial endometrioid carcinoma - APPLY NOW for a 3 year PhD opportunity: ed.ac.uk/cancer-centre/…

Edinburgh researchers used unique dataset that combines hormone receptor expression patterns with matched genomic characterisation to identify opportunities for patient stratification in endometrioid ovarian carcinoma: ed.ac.uk/cancer-centre/…

Congratulations to the winners of this year’s Early Career Awards! We created the programme to give researchers from MRC_HGU Edinburgh Cancer Research & Centre for Genomic and Experimental Medicine the opportunity to develop new ideas, novel training & practice in applying for research funding. More here: ed.ac.uk/institute-gene…

Integrated genomic and histopathological analysis of low grade serous ovarian carcinoma identifies clinically distinct disease subtypes medrxiv.org/cgi/content/sh… #medRxiv

Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high grade serous carcinoma medrxiv.org/cgi/content/sh… #medRxiv

WE'RE HIRING A POSTDOC! 🎉 Are you excited to develop and apply statistical and computational methods to disentangle the structural variant landscape in tumours? ewinggroup.github.io/launches/2022/… Apply here: closing date 7th June 5pm elxw.fa.em3.oraclecloud.com/hcmUI/Candidat… 📸 Craig Nicol Institute of Genetics and Cancer

Very proud to have been involved in the biospecimen analysis of this trial 🤓 great to see new agents becoming available for ovarian cancer patients #science #cancer #CancerResearch

Proud to share our latest research published in Clinical Cancer Research, using multiomic profiling to stratify high grade serous ovarian cancer patients Edinburgh Cancer Research Institute of Genetics and Cancer The University of Edinburgh aacrjournals.org/clincancerres/…

Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratification - work led by Edinburgh Cancer Research investigators helps define patients who may benefit most from specific molecular therapeutics. Published by Clinical Cancer Research👇: aacrjournals.org/clincancerres/…

New study of ovarian carcinosarcoma (OCS) published by Edinburgh Cancer Research researchers in British Journal of Cancer ! The work defines OCS as a distinct form of #ovarian #cancer with poorer survival and highlights the urgent need for improved treatment strategies for OCS patients: nature.com/articles/s4141…

Edinburgh Cancer Research led study published in Clinical Cancer Research provides high-resolution picture of the molecular landscape in high-grade serous ovarian carcinoma that may benefit #ovarian #cancer patients! Read more on our website👇: ed.ac.uk/cancer-centre/…

Edinburgh Cancer Research scientists report clinical and histopathological characterisation of the largest pathologically confirmed cohort of ovarian carcinosarcoma patients to date. New insights into this rare form of #ovariancancer! Published in British Journal of Cancer. Lay summary: ed.ac.uk/cancer-centre/…

Congratulations Ailith Ewing, Ava Khamseh and Robb Hollis . Many thanks to Hugh and Josseline Langmuir for making this possible.

Read more about how a surgical resection outcome depends on ovarian cancer type: ed.ac.uk/cancer-centre/… Edinburgh Cancer Research Robb Hollis Institute for Regeneration and Repair Royal Infirmary of Edinburgh

[3/3] Robb Hollis will study events leading to chemoresistance in #ovariancancer using carcinosarcoma as a model of complete epithelial-to-mesenchymal transition and identify targeted therapeutic strategies to prevent treatment failure. #CRUKFunded | The University of Edinburgh

On #InternationalOvarianCancerDay, we held a Shining the Light on Ovarian Cancer event where Professor Charlie Gourley, Dr Rob Hollis and Dr Sarah Taylor talked about how their research is driving personalised patient care & Christine Macleod shared her story of going through treatment.

Come to our Secret Garden tomorrow at Big Bang London! The Big Bang @ London #tbb_london #beauty #science #cosmetics